Earth Science Tech (ETST) Non-Current Assets (2014 - 2026)
Earth Science Tech's (ETST) quarterly Non-Current Assets came in at $5.2 million in Q1 2026, up 32.66% YoY from $4.0 million in Q1 2025, and up 3.79% on a QoQ basis from $5.1 million in Q4 2025.
Earth Science Tech (ETST) Non-Current Assets (2014 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 11 years of Non-Current Assets data on file, last reported at $5.2 million in Q1 2026.
- Quarterly Non-Current Assets rose 32.66% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 million (up 52.95% YoY) and the FY2026 annual result came in at $5.2 million, up 32.66% from the prior year.
- Non-Current Assets improved to $5.2 million in Q1 2026, from $5.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $5.2 million in Q1 2026 to a low of $50000.0 in Q1 2022.
- A 5-year average of $2.8 million and a median of $2.7 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 5626.97% — and 2024, when it dropped 2.19%.
- Tracing ETST's Non-Current Assets over 5 years: stood at $513188.0 in 2022, then soared by 400.77% to $2.6 million in 2023, then soared by 44.08% to $3.7 million in 2024, then surged by 36.56% to $5.1 million in 2025, then grew by 3.79% to $5.2 million in 2026.
- The last three Non-Current Assets figures came in at $5.2 million (Q1 2026), $5.1 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Earth Science Tech | 34.80 Mn | 31.98 Mn | 6.28 Mn | 5.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.29 Mn |
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 5.06 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.75 Mn |
| Mar 31, 2023 | 2.68 Mn |
| Dec 31, 2022 | 513,188.00 |
| Sep 30, 2022 | 354,557.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Sep 30, 2021 | 6,191.00 |
| Jun 30, 2021 | 6,191.00 |